Overview: Enterovirus PCR TestIntroduction: The Enterovirus PCR Test detects enterovirus DNA, confirming active infection causing fever or neurological symptoms. Aligned with 2023 IDSA guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected active enterovirus infections.
Other Names: Enterovirus PCR Assay, Enterovirus DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Enterovirus PCR testing began in the 1990s with molecular diagnostics. Real-time PCR emerged in the 2000s, improving detection accuracy for active infections.
Purpose: Confirms active enterovirus infection, guides supportive care, and monitors viral DNA in patients with fever or neurological symptoms.
Test Parameters: 1. Enterovirus DNA
Pretest Condition: No fasting required. Collect whole blood, CSF, stool, swab, or saliva at any time. Report symptoms like fever or neurological issues, and list recent viral exposures.
Specimen: 2-5 mL whole blood (EDTA), 1-2 mL CSF (sterile container), 5-10 g stool (sterile container), 1-2 swabs (sterile swab/transport medium), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, neurological symptoms, or recent viral exposures. Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for supportive care.
Procedural Considerations: Uses real-time PCR to detect enterovirus DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Low viral load or improper storage can cause false negatives. Contamination may cause false positives.
Clinical Significance: Positive DNA results confirm active enterovirus infection, prompting supportive care. Negative results may require antigen or repeat testing.
Specialist Consultation: Consult an infectious disease specialist or neurologist for result interpretation.
Additional Supporting Tests: Enterovirus antigen test, CSF analysis, or neuroimaging to confirm infection or assess complications.
Test Limitations: False negatives may occur with low viral load. Results require clinical correlation.
References: IDSA Enterovirus Guidelines, 2023; Clinical Infectious Diseases, Pallansch MA, 2022.
